PubMed:10406849 JSONTXT

Annnotations TAB JSON ListView MergeView

    Glycan-Motif

    {"project":"Glycan-Motif","denotations":[{"id":"T1","span":{"begin":60,"end":67},"obj":"https://glytoucan.org/Structures/Glycans/G70323CJ"},{"id":"T2","span":{"begin":673,"end":680},"obj":"https://glytoucan.org/Structures/Glycans/G70323CJ"},{"id":"T3","span":{"begin":798,"end":805},"obj":"https://glytoucan.org/Structures/Glycans/G70323CJ"},{"id":"T4","span":{"begin":1324,"end":1331},"obj":"https://glytoucan.org/Structures/Glycans/G70323CJ"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    GlyCosmos6-Glycan-Motif-Image

    {"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":60,"end":67},"obj":"Glycan_Motif"},{"id":"T2","span":{"begin":673,"end":680},"obj":"Glycan_Motif"},{"id":"T3","span":{"begin":798,"end":805},"obj":"Glycan_Motif"},{"id":"T4","span":{"begin":1324,"end":1331},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G70323CJ"},{"id":"A2","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G70323CJ"},{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G70323CJ"},{"id":"A4","pred":"image","subj":"T4","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G70323CJ"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    GlyCosmos6-Glycan-Motif-Structure

    {"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":60,"end":67},"obj":"https://glytoucan.org/Structures/Glycans/G70323CJ"},{"id":"T2","span":{"begin":673,"end":680},"obj":"https://glytoucan.org/Structures/Glycans/G70323CJ"},{"id":"T3","span":{"begin":798,"end":805},"obj":"https://glytoucan.org/Structures/Glycans/G70323CJ"},{"id":"T4","span":{"begin":1324,"end":1331},"obj":"https://glytoucan.org/Structures/Glycans/G70323CJ"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    Glycosmos6-MAT

    {"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":315,"end":321},"obj":"http://purl.obolibrary.org/obo/MAT_0000484"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    GlycoBiology-FMA

    {"project":"GlycoBiology-FMA","denotations":[{"id":"_T1","span":{"begin":19,"end":35},"obj":"FMAID:198528"},{"id":"_T2","span":{"begin":19,"end":35},"obj":"FMAID:89997"},{"id":"_T3","span":{"begin":28,"end":35},"obj":"FMAID:165447"},{"id":"_T4","span":{"begin":28,"end":35},"obj":"FMAID:67257"},{"id":"_T5","span":{"begin":60,"end":67},"obj":"FMAID:196796"},{"id":"_T6","span":{"begin":60,"end":67},"obj":"FMAID:82801"},{"id":"_T7","span":{"begin":129,"end":134},"obj":"FMAID:169002"},{"id":"_T8","span":{"begin":129,"end":134},"obj":"FMAID:68646"},{"id":"_T9","span":{"begin":166,"end":182},"obj":"FMAID:198528"},{"id":"_T10","span":{"begin":166,"end":182},"obj":"FMAID:89997"},{"id":"_T11","span":{"begin":175,"end":182},"obj":"FMAID:165447"},{"id":"_T12","span":{"begin":175,"end":182},"obj":"FMAID:67257"},{"id":"_T13","span":{"begin":230,"end":235},"obj":"FMAID:169002"},{"id":"_T14","span":{"begin":230,"end":235},"obj":"FMAID:68646"},{"id":"_T15","span":{"begin":230,"end":250},"obj":"FMAID:86454"},{"id":"_T16","span":{"begin":230,"end":250},"obj":"FMAID:200882"},{"id":"_T17","span":{"begin":254,"end":264},"obj":"FMAID:82780"},{"id":"_T18","span":{"begin":254,"end":264},"obj":"FMAID:196773"},{"id":"_T19","span":{"begin":329,"end":337},"obj":"FMAID:165447"},{"id":"_T20","span":{"begin":329,"end":337},"obj":"FMAID:67257"},{"id":"_T21","span":{"begin":347,"end":354},"obj":"FMAID:74550"},{"id":"_T22","span":{"begin":347,"end":354},"obj":"FMAID:179287"},{"id":"_T23","span":{"begin":391,"end":396},"obj":"FMAID:214748"},{"id":"_T24","span":{"begin":483,"end":495},"obj":"FMAID:197276"},{"id":"_T25","span":{"begin":483,"end":495},"obj":"FMAID:82737"},{"id":"_T26","span":{"begin":557,"end":564},"obj":"FMAID:165447"},{"id":"_T27","span":{"begin":557,"end":564},"obj":"FMAID:67257"},{"id":"_T28","span":{"begin":600,"end":607},"obj":"FMAID:179287"},{"id":"_T29","span":{"begin":600,"end":607},"obj":"FMAID:74550"},{"id":"_T30","span":{"begin":673,"end":680},"obj":"FMAID:196796"},{"id":"_T31","span":{"begin":673,"end":680},"obj":"FMAID:82801"},{"id":"_T32","span":{"begin":757,"end":767},"obj":"FMAID:196739"},{"id":"_T33","span":{"begin":757,"end":767},"obj":"FMAID:82750"},{"id":"_T34","span":{"begin":798,"end":805},"obj":"FMAID:82801"},{"id":"_T35","span":{"begin":798,"end":805},"obj":"FMAID:196796"},{"id":"_T36","span":{"begin":1078,"end":1091},"obj":"FMAID:169236"},{"id":"_T37","span":{"begin":1078,"end":1091},"obj":"FMAID:68833"},{"id":"_T38","span":{"begin":1181,"end":1188},"obj":"FMAID:50594"},{"id":"_T39","span":{"begin":1181,"end":1188},"obj":"FMAID:146300"},{"id":"_T40","span":{"begin":1291,"end":1304},"obj":"FMAID:62925"},{"id":"_T41","span":{"begin":1291,"end":1304},"obj":"FMAID:167256"},{"id":"_T42","span":{"begin":1324,"end":1331},"obj":"FMAID:82801"},{"id":"_T43","span":{"begin":1324,"end":1331},"obj":"FMAID:196796"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    uniprot-human

    {"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":37,"end":42},"obj":"http://www.uniprot.org/uniprot/Q12907"},{"id":"T2","span":{"begin":184,"end":189},"obj":"http://www.uniprot.org/uniprot/Q12907"},{"id":"T3","span":{"begin":472,"end":477},"obj":"http://www.uniprot.org/uniprot/Q12907"},{"id":"T4","span":{"begin":519,"end":524},"obj":"http://www.uniprot.org/uniprot/Q12907"},{"id":"T5","span":{"begin":618,"end":623},"obj":"http://www.uniprot.org/uniprot/Q12907"},{"id":"T6","span":{"begin":651,"end":656},"obj":"http://www.uniprot.org/uniprot/Q12907"},{"id":"T7","span":{"begin":1236,"end":1241},"obj":"http://www.uniprot.org/uniprot/Q12907"},{"id":"T8","span":{"begin":409,"end":417},"obj":"http://www.uniprot.org/uniprot/Q9UQG6"},{"id":"T9","span":{"begin":584,"end":595},"obj":"http://www.uniprot.org/uniprot/Q99484"},{"id":"T10","span":{"begin":1078,"end":1091},"obj":"http://www.uniprot.org/uniprot/Q9UNY3"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    uniprot-mouse

    {"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":37,"end":42},"obj":"http://www.uniprot.org/uniprot/Q9DBH5"},{"id":"T2","span":{"begin":184,"end":189},"obj":"http://www.uniprot.org/uniprot/Q9DBH5"},{"id":"T3","span":{"begin":472,"end":477},"obj":"http://www.uniprot.org/uniprot/Q9DBH5"},{"id":"T4","span":{"begin":519,"end":524},"obj":"http://www.uniprot.org/uniprot/Q9DBH5"},{"id":"T5","span":{"begin":618,"end":623},"obj":"http://www.uniprot.org/uniprot/Q9DBH5"},{"id":"T6","span":{"begin":651,"end":656},"obj":"http://www.uniprot.org/uniprot/Q9DBH5"},{"id":"T7","span":{"begin":1236,"end":1241},"obj":"http://www.uniprot.org/uniprot/Q9DBH5"},{"id":"T8","span":{"begin":315,"end":321},"obj":"http://www.uniprot.org/uniprot/P28352"},{"id":"T9","span":{"begin":409,"end":417},"obj":"http://www.uniprot.org/uniprot/Q9D0F3"},{"id":"T10","span":{"begin":584,"end":595},"obj":"http://www.uniprot.org/uniprot/P38649"},{"id":"T11","span":{"begin":716,"end":719},"obj":"http://www.uniprot.org/uniprot/A2APV2"},{"id":"T12","span":{"begin":958,"end":961},"obj":"http://www.uniprot.org/uniprot/A2APV2"},{"id":"T13","span":{"begin":1049,"end":1052},"obj":"http://www.uniprot.org/uniprot/A2APV2"},{"id":"T14","span":{"begin":1367,"end":1370},"obj":"http://www.uniprot.org/uniprot/A2APV2"},{"id":"T15","span":{"begin":984,"end":987},"obj":"http://www.uniprot.org/uniprot/Q61024"},{"id":"T16","span":{"begin":1078,"end":1091},"obj":"http://www.uniprot.org/uniprot/O08710"},{"id":"T17","span":{"begin":1129,"end":1133},"obj":"http://www.uniprot.org/uniprot/P17717"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    GlycoBiology-NCBITAXON

    {"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T1","span":{"begin":0,"end":9},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/246680"},{"id":"T2","span":{"begin":129,"end":134},"obj":"http://purl.bioontology.org/ontology/STY/T025"},{"id":"T3","span":{"begin":147,"end":156},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/246680"},{"id":"T4","span":{"begin":230,"end":235},"obj":"http://purl.bioontology.org/ontology/STY/T025"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":135},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":136,"end":418},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":419,"end":632},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":633,"end":768},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":769,"end":896},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":897,"end":977},"obj":"Sentence"},{"id":"TextSentencer_T7","span":{"begin":978,"end":983},"obj":"Sentence"},{"id":"TextSentencer_T8","span":{"begin":984,"end":1015},"obj":"Sentence"},{"id":"TextSentencer_T9","span":{"begin":1016,"end":1207},"obj":"Sentence"},{"id":"TextSentencer_T10","span":{"begin":1208,"end":1374},"obj":"Sentence"},{"id":"TextSentencer_T11","span":{"begin":1375,"end":1385},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":135},"obj":"Sentence"},{"id":"T2","span":{"begin":136,"end":418},"obj":"Sentence"},{"id":"T3","span":{"begin":419,"end":632},"obj":"Sentence"},{"id":"T4","span":{"begin":633,"end":768},"obj":"Sentence"},{"id":"T5","span":{"begin":769,"end":977},"obj":"Sentence"},{"id":"T6","span":{"begin":978,"end":1207},"obj":"Sentence"},{"id":"T7","span":{"begin":1208,"end":1374},"obj":"Sentence"},{"id":"T8","span":{"begin":1375,"end":1385},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":135},"obj":"Sentence"},{"id":"T2","span":{"begin":136,"end":418},"obj":"Sentence"},{"id":"T3","span":{"begin":419,"end":632},"obj":"Sentence"},{"id":"T4","span":{"begin":633,"end":768},"obj":"Sentence"},{"id":"T5","span":{"begin":769,"end":896},"obj":"Sentence"},{"id":"T6","span":{"begin":897,"end":977},"obj":"Sentence"},{"id":"T7","span":{"begin":978,"end":983},"obj":"Sentence"},{"id":"T8","span":{"begin":984,"end":1015},"obj":"Sentence"},{"id":"T9","span":{"begin":1016,"end":1207},"obj":"Sentence"},{"id":"T10","span":{"begin":1208,"end":1374},"obj":"Sentence"},{"id":"T11","span":{"begin":1375,"end":1385},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T1","span":{"begin":103,"end":111},"obj":"http://purl.obolibrary.org/obo/GO_0097502"},{"id":"T2","span":{"begin":838,"end":840},"obj":"http://purl.obolibrary.org/obo/GO_0033968"},{"id":"T3","span":{"begin":929,"end":954},"obj":"http://purl.obolibrary.org/obo/GO_0051100"},{"id":"T4","span":{"begin":980,"end":982},"obj":"http://purl.obolibrary.org/obo/GO_0003987"},{"id":"T5","span":{"begin":980,"end":982},"obj":"http://purl.obolibrary.org/obo/GO_0043884"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    GO-MF

    {"project":"GO-MF","denotations":[{"id":"T1","span":{"begin":483,"end":503},"obj":"http://purl.obolibrary.org/obo/GO_0030246"},{"id":"T2","span":{"begin":496,"end":503},"obj":"http://purl.obolibrary.org/obo/GO_0070026"},{"id":"T3","span":{"begin":773,"end":780},"obj":"http://purl.obolibrary.org/obo/GO_0070026"},{"id":"T4","span":{"begin":947,"end":954},"obj":"http://purl.obolibrary.org/obo/GO_0070026"},{"id":"T5","span":{"begin":496,"end":503},"obj":"http://purl.obolibrary.org/obo/GO_0003680"},{"id":"T6","span":{"begin":773,"end":780},"obj":"http://purl.obolibrary.org/obo/GO_0003680"},{"id":"T7","span":{"begin":947,"end":954},"obj":"http://purl.obolibrary.org/obo/GO_0003680"},{"id":"T8","span":{"begin":496,"end":503},"obj":"http://purl.obolibrary.org/obo/GO_0017091"},{"id":"T9","span":{"begin":773,"end":780},"obj":"http://purl.obolibrary.org/obo/GO_0017091"},{"id":"T10","span":{"begin":947,"end":954},"obj":"http://purl.obolibrary.org/obo/GO_0017091"},{"id":"T11","span":{"begin":496,"end":503},"obj":"http://purl.obolibrary.org/obo/GO_0005488"},{"id":"T12","span":{"begin":773,"end":780},"obj":"http://purl.obolibrary.org/obo/GO_0005488"},{"id":"T13","span":{"begin":947,"end":954},"obj":"http://purl.obolibrary.org/obo/GO_0005488"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    GO-CC

    {"project":"GO-CC","denotations":[{"id":"T1","span":{"begin":10,"end":27},"obj":"http://purl.obolibrary.org/obo/GO_0016021"},{"id":"T2","span":{"begin":157,"end":174},"obj":"http://purl.obolibrary.org/obo/GO_0016021"},{"id":"T3","span":{"begin":10,"end":35},"obj":"http://purl.obolibrary.org/obo/GO_0097631"},{"id":"T4","span":{"begin":157,"end":182},"obj":"http://purl.obolibrary.org/obo/GO_0097631"},{"id":"T5","span":{"begin":10,"end":35},"obj":"http://purl.obolibrary.org/obo/GO_0030173"},{"id":"T6","span":{"begin":157,"end":182},"obj":"http://purl.obolibrary.org/obo/GO_0030173"},{"id":"T7","span":{"begin":10,"end":35},"obj":"http://purl.obolibrary.org/obo/GO_0030176"},{"id":"T8","span":{"begin":157,"end":182},"obj":"http://purl.obolibrary.org/obo/GO_0030176"},{"id":"T9","span":{"begin":19,"end":27},"obj":"http://purl.obolibrary.org/obo/GO_0016020"},{"id":"T10","span":{"begin":166,"end":174},"obj":"http://purl.obolibrary.org/obo/GO_0016020"},{"id":"T11","span":{"begin":129,"end":134},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T12","span":{"begin":230,"end":235},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T13","span":{"begin":409,"end":414},"obj":"http://purl.obolibrary.org/obo/GO_0005793"},{"id":"T14","span":{"begin":1258,"end":1271},"obj":"http://purl.obolibrary.org/obo/GO_0005622"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    EDAM-topics

    {"project":"EDAM-topics","denotations":[{"id":"T1","span":{"begin":19,"end":35},"obj":"http://edamontology.org/topic_0820"},{"id":"T2","span":{"begin":28,"end":35},"obj":"http://edamontology.org/topic_0078"},{"id":"T3","span":{"begin":166,"end":182},"obj":"http://edamontology.org/topic_0820"},{"id":"T4","span":{"begin":175,"end":182},"obj":"http://edamontology.org/topic_0078"},{"id":"T5","span":{"begin":329,"end":337},"obj":"http://edamontology.org/topic_0078"},{"id":"T6","span":{"begin":391,"end":396},"obj":"http://edamontology.org/topic_0780"},{"id":"T7","span":{"begin":483,"end":495},"obj":"http://edamontology.org/topic_0152"},{"id":"T8","span":{"begin":557,"end":564},"obj":"http://edamontology.org/topic_0078"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    EDAM-DFO

    {"project":"EDAM-DFO","denotations":[{"id":"T1","span":{"begin":28,"end":35},"obj":"http://edamontology.org/format_1208"},{"id":"T2","span":{"begin":28,"end":35},"obj":"http://edamontology.org/data_1467"},{"id":"T3","span":{"begin":112,"end":120},"obj":"http://edamontology.org/data_1756"},{"id":"T4","span":{"begin":175,"end":182},"obj":"http://edamontology.org/data_1467"},{"id":"T5","span":{"begin":175,"end":182},"obj":"http://edamontology.org/format_1208"},{"id":"T6","span":{"begin":329,"end":337},"obj":"http://edamontology.org/format_1208"},{"id":"T7","span":{"begin":329,"end":337},"obj":"http://edamontology.org/data_1467"},{"id":"T8","span":{"begin":437,"end":448},"obj":"http://edamontology.org/data_2576"},{"id":"T9","span":{"begin":437,"end":448},"obj":"http://edamontology.org/data_0977"},{"id":"T10","span":{"begin":440,"end":448},"obj":"http://edamontology.org/data_2611"},{"id":"T11","span":{"begin":440,"end":448},"obj":"http://edamontology.org/data_0842"},{"id":"T12","span":{"begin":557,"end":564},"obj":"http://edamontology.org/data_1467"},{"id":"T13","span":{"begin":557,"end":564},"obj":"http://edamontology.org/format_1208"},{"id":"T14","span":{"begin":720,"end":728},"obj":"http://edamontology.org/data_1756"},{"id":"T15","span":{"begin":873,"end":875},"obj":"http://edamontology.org/format_1997"},{"id":"T16","span":{"begin":901,"end":914},"obj":"http://edamontology.org/data_2140"},{"id":"T17","span":{"begin":1242,"end":1251},"obj":"http://edamontology.org/operation_0004"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    NGLY1-deficiency

    {"project":"NGLY1-deficiency","denotations":[{"id":"PD-NGLY1-deficiency-B_T1","span":{"begin":967,"end":973},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T2","span":{"begin":1058,"end":1064},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T3","span":{"begin":1375,"end":1381},"obj":"chem:24139"}],"namespaces":[{"prefix":"hgnc","uri":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:"},{"prefix":"omim","uri":"https://www.omim.org/entry/"},{"prefix":"chem","uri":"https://pubchem.ncbi.nlm.nih.gov/compound/"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    GlycoBiology-MAT

    {"project":"GlycoBiology-MAT","denotations":[{"id":"T1","span":{"begin":315,"end":321},"obj":"http://purl.obolibrary.org/obo/MAT_0000484"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    GlycoBiology-Motifs

    {"project":"GlycoBiology-Motifs","denotations":[{"id":"T1","span":{"begin":55,"end":67},"obj":"http://rdf.glycoinfo.org/glycan/G00028MO"},{"id":"T2","span":{"begin":668,"end":680},"obj":"http://rdf.glycoinfo.org/glycan/G00028MO"},{"id":"T3","span":{"begin":793,"end":805},"obj":"http://rdf.glycoinfo.org/glycan/G00028MO"},{"id":"T4","span":{"begin":1319,"end":1331},"obj":"http://rdf.glycoinfo.org/glycan/G00028MO"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    Lectin

    {"project":"Lectin","denotations":[{"id":"Lectin_T1","span":{"begin":716,"end":719},"obj":"https://acgg.asia/db/lfdb/LfDB0217"},{"id":"Lectin_T2","span":{"begin":958,"end":961},"obj":"https://acgg.asia/db/lfdb/LfDB0217"},{"id":"Lectin_T3","span":{"begin":1049,"end":1052},"obj":"https://acgg.asia/db/lfdb/LfDB0217"},{"id":"Lectin_T4","span":{"begin":1367,"end":1370},"obj":"https://acgg.asia/db/lfdb/LfDB0217"},{"id":"Lectin_T5","span":{"begin":838,"end":840},"obj":"https://acgg.asia/db/lfdb/LfDB0227"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    GlyTouCan-IUPAC

    {"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G19151BJ\""},{"id":"GlycanIUPAC_T2","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G19151BJ\""},{"id":"GlycanIUPAC_T3","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G19151BJ\""},{"id":"GlycanIUPAC_T4","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G19151BJ\""},{"id":"GlycanIUPAC_T5","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G63727IH\""},{"id":"GlycanIUPAC_T6","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G63727IH\""},{"id":"GlycanIUPAC_T7","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G63727IH\""},{"id":"GlycanIUPAC_T8","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G63727IH\""},{"id":"GlycanIUPAC_T9","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G05795KA\""},{"id":"GlycanIUPAC_T10","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G05795KA\""},{"id":"GlycanIUPAC_T11","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G05795KA\""},{"id":"GlycanIUPAC_T12","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G05795KA\""},{"id":"GlycanIUPAC_T13","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G90812SJ\""},{"id":"GlycanIUPAC_T14","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G90812SJ\""},{"id":"GlycanIUPAC_T15","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G90812SJ\""},{"id":"GlycanIUPAC_T16","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G90812SJ\""},{"id":"GlycanIUPAC_T17","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G07124DB\""},{"id":"GlycanIUPAC_T18","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G07124DB\""},{"id":"GlycanIUPAC_T19","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G07124DB\""},{"id":"GlycanIUPAC_T20","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G07124DB\""},{"id":"GlycanIUPAC_T21","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G20567HS\""},{"id":"GlycanIUPAC_T22","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G20567HS\""},{"id":"GlycanIUPAC_T23","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G20567HS\""},{"id":"GlycanIUPAC_T24","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G20567HS\""},{"id":"GlycanIUPAC_T25","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G76159WX\""},{"id":"GlycanIUPAC_T26","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G76159WX\""},{"id":"GlycanIUPAC_T27","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G76159WX\""},{"id":"GlycanIUPAC_T28","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G76159WX\""},{"id":"GlycanIUPAC_T29","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G40623UW\""},{"id":"GlycanIUPAC_T30","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G40623UW\""},{"id":"GlycanIUPAC_T31","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G40623UW\""},{"id":"GlycanIUPAC_T32","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G40623UW\""},{"id":"GlycanIUPAC_T33","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G06447MP\""},{"id":"GlycanIUPAC_T34","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G06447MP\""},{"id":"GlycanIUPAC_T35","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G06447MP\""},{"id":"GlycanIUPAC_T36","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G06447MP\""},{"id":"GlycanIUPAC_T37","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G62764VZ\""},{"id":"GlycanIUPAC_T38","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G62764VZ\""},{"id":"GlycanIUPAC_T39","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G62764VZ\""},{"id":"GlycanIUPAC_T40","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G62764VZ\""},{"id":"GlycanIUPAC_T41","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G21434YY\""},{"id":"GlycanIUPAC_T42","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G21434YY\""},{"id":"GlycanIUPAC_T43","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G21434YY\""},{"id":"GlycanIUPAC_T44","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G21434YY\""},{"id":"GlycanIUPAC_T45","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G34267PK\""},{"id":"GlycanIUPAC_T46","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G34267PK\""},{"id":"GlycanIUPAC_T47","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G34267PK\""},{"id":"GlycanIUPAC_T48","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G34267PK\""},{"id":"GlycanIUPAC_T49","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G30235PC\""},{"id":"GlycanIUPAC_T50","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G30235PC\""},{"id":"GlycanIUPAC_T51","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G30235PC\""},{"id":"GlycanIUPAC_T52","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G30235PC\""},{"id":"GlycanIUPAC_T53","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G34820UC\""},{"id":"GlycanIUPAC_T54","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G34820UC\""},{"id":"GlycanIUPAC_T55","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G34820UC\""},{"id":"GlycanIUPAC_T56","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G34820UC\""},{"id":"GlycanIUPAC_T57","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G95531HX\""},{"id":"GlycanIUPAC_T58","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G95531HX\""},{"id":"GlycanIUPAC_T59","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G95531HX\""},{"id":"GlycanIUPAC_T60","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G95531HX\""},{"id":"GlycanIUPAC_T61","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G74672YG\""},{"id":"GlycanIUPAC_T62","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G74672YG\""},{"id":"GlycanIUPAC_T63","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G74672YG\""},{"id":"GlycanIUPAC_T64","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G74672YG\""},{"id":"GlycanIUPAC_T65","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G54440FW\""},{"id":"GlycanIUPAC_T66","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G54440FW\""},{"id":"GlycanIUPAC_T67","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G54440FW\""},{"id":"GlycanIUPAC_T68","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G54440FW\""},{"id":"GlycanIUPAC_T69","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G69182II\""},{"id":"GlycanIUPAC_T70","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G69182II\""},{"id":"GlycanIUPAC_T71","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G69182II\""},{"id":"GlycanIUPAC_T72","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G69182II\""},{"id":"GlycanIUPAC_T73","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G68961XX\""},{"id":"GlycanIUPAC_T74","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G68961XX\""},{"id":"GlycanIUPAC_T75","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G68961XX\""},{"id":"GlycanIUPAC_T76","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G68961XX\""},{"id":"GlycanIUPAC_T77","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G11710CQ\""},{"id":"GlycanIUPAC_T78","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G11710CQ\""},{"id":"GlycanIUPAC_T79","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G11710CQ\""},{"id":"GlycanIUPAC_T80","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G11710CQ\""},{"id":"GlycanIUPAC_T81","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G70765DS\""},{"id":"GlycanIUPAC_T82","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G70765DS\""},{"id":"GlycanIUPAC_T83","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G70765DS\""},{"id":"GlycanIUPAC_T84","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G70765DS\""},{"id":"GlycanIUPAC_T85","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G51661YR\""},{"id":"GlycanIUPAC_T86","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G51661YR\""},{"id":"GlycanIUPAC_T87","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G51661YR\""},{"id":"GlycanIUPAC_T88","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G51661YR\""},{"id":"GlycanIUPAC_T89","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G18477VG\""},{"id":"GlycanIUPAC_T90","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G18477VG\""},{"id":"GlycanIUPAC_T91","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G18477VG\""},{"id":"GlycanIUPAC_T92","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G18477VG\""},{"id":"GlycanIUPAC_T93","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G12337MH\""},{"id":"GlycanIUPAC_T94","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G12337MH\""},{"id":"GlycanIUPAC_T95","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G12337MH\""},{"id":"GlycanIUPAC_T96","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G12337MH\""},{"id":"GlycanIUPAC_T97","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G40783MY\""},{"id":"GlycanIUPAC_T98","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G40783MY\""},{"id":"GlycanIUPAC_T99","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G40783MY\""},{"id":"GlycanIUPAC_T100","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G40783MY\""},{"id":"GlycanIUPAC_T101","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G72867LN\""},{"id":"GlycanIUPAC_T102","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G72867LN\""},{"id":"GlycanIUPAC_T103","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G72867LN\""},{"id":"GlycanIUPAC_T104","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G72867LN\""},{"id":"GlycanIUPAC_T105","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G79061OT\""},{"id":"GlycanIUPAC_T106","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G79061OT\""},{"id":"GlycanIUPAC_T107","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G79061OT\""},{"id":"GlycanIUPAC_T108","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G79061OT\""},{"id":"GlycanIUPAC_T109","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G45970UX\""},{"id":"GlycanIUPAC_T110","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G45970UX\""},{"id":"GlycanIUPAC_T111","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G45970UX\""},{"id":"GlycanIUPAC_T112","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G45970UX\""},{"id":"GlycanIUPAC_T113","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G93661NW\""},{"id":"GlycanIUPAC_T114","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G93661NW\""},{"id":"GlycanIUPAC_T115","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G93661NW\""},{"id":"GlycanIUPAC_T116","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G93661NW\""},{"id":"GlycanIUPAC_T117","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G04988XL\""},{"id":"GlycanIUPAC_T118","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G04988XL\""},{"id":"GlycanIUPAC_T119","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G04988XL\""},{"id":"GlycanIUPAC_T120","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G04988XL\""},{"id":"GlycanIUPAC_T121","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G85800UH\""},{"id":"GlycanIUPAC_T122","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G85800UH\""},{"id":"GlycanIUPAC_T123","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G85800UH\""},{"id":"GlycanIUPAC_T124","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G85800UH\""},{"id":"GlycanIUPAC_T125","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G96338GZ\""},{"id":"GlycanIUPAC_T126","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G96338GZ\""},{"id":"GlycanIUPAC_T127","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G96338GZ\""},{"id":"GlycanIUPAC_T128","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G96338GZ\""},{"id":"GlycanIUPAC_T129","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G96296PU\""},{"id":"GlycanIUPAC_T130","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G96296PU\""},{"id":"GlycanIUPAC_T131","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G96296PU\""},{"id":"GlycanIUPAC_T132","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G96296PU\""},{"id":"GlycanIUPAC_T133","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G59124WZ\""},{"id":"GlycanIUPAC_T134","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G59124WZ\""},{"id":"GlycanIUPAC_T135","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G59124WZ\""},{"id":"GlycanIUPAC_T136","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G59124WZ\""},{"id":"GlycanIUPAC_T137","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G57275GR\""},{"id":"GlycanIUPAC_T138","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G57275GR\""},{"id":"GlycanIUPAC_T139","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G57275GR\""},{"id":"GlycanIUPAC_T140","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G57275GR\""},{"id":"GlycanIUPAC_T141","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G46105MZ\""},{"id":"GlycanIUPAC_T142","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G46105MZ\""},{"id":"GlycanIUPAC_T143","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G46105MZ\""},{"id":"GlycanIUPAC_T144","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G46105MZ\""},{"id":"GlycanIUPAC_T145","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G76001GO\""},{"id":"GlycanIUPAC_T146","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G76001GO\""},{"id":"GlycanIUPAC_T147","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G76001GO\""},{"id":"GlycanIUPAC_T148","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G76001GO\""},{"id":"GlycanIUPAC_T149","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G89599ML\""},{"id":"GlycanIUPAC_T150","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G89599ML\""},{"id":"GlycanIUPAC_T151","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G89599ML\""},{"id":"GlycanIUPAC_T152","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G89599ML\""},{"id":"GlycanIUPAC_T153","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G85872BD\""},{"id":"GlycanIUPAC_T154","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G85872BD\""},{"id":"GlycanIUPAC_T155","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G85872BD\""},{"id":"GlycanIUPAC_T156","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G85872BD\""},{"id":"GlycanIUPAC_T157","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G69460YK\""},{"id":"GlycanIUPAC_T158","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G69460YK\""},{"id":"GlycanIUPAC_T159","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G69460YK\""},{"id":"GlycanIUPAC_T160","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G69460YK\""},{"id":"GlycanIUPAC_T161","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G25240JV\""},{"id":"GlycanIUPAC_T162","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G25240JV\""},{"id":"GlycanIUPAC_T163","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G25240JV\""},{"id":"GlycanIUPAC_T164","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G25240JV\""},{"id":"GlycanIUPAC_T165","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G80489OS\""},{"id":"GlycanIUPAC_T166","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G80489OS\""},{"id":"GlycanIUPAC_T167","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G80489OS\""},{"id":"GlycanIUPAC_T168","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G80489OS\""},{"id":"GlycanIUPAC_T169","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G35726XK\""},{"id":"GlycanIUPAC_T170","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G35726XK\""},{"id":"GlycanIUPAC_T171","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G35726XK\""},{"id":"GlycanIUPAC_T172","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G35726XK\""},{"id":"GlycanIUPAC_T173","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G11002JA\""},{"id":"GlycanIUPAC_T174","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G11002JA\""},{"id":"GlycanIUPAC_T175","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G11002JA\""},{"id":"GlycanIUPAC_T176","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G11002JA\""},{"id":"GlycanIUPAC_T177","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G85388FO\""},{"id":"GlycanIUPAC_T178","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G85388FO\""},{"id":"GlycanIUPAC_T179","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G85388FO\""},{"id":"GlycanIUPAC_T180","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G85388FO\""},{"id":"GlycanIUPAC_T181","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G20221JL\""},{"id":"GlycanIUPAC_T182","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G20221JL\""},{"id":"GlycanIUPAC_T183","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G20221JL\""},{"id":"GlycanIUPAC_T184","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G20221JL\""},{"id":"GlycanIUPAC_T185","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G39026SP\""},{"id":"GlycanIUPAC_T186","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G39026SP\""},{"id":"GlycanIUPAC_T187","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G39026SP\""},{"id":"GlycanIUPAC_T188","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G39026SP\""},{"id":"GlycanIUPAC_T189","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G66979UZ\""},{"id":"GlycanIUPAC_T190","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G66979UZ\""},{"id":"GlycanIUPAC_T191","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G66979UZ\""},{"id":"GlycanIUPAC_T192","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G66979UZ\""},{"id":"GlycanIUPAC_T193","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G68566EA\""},{"id":"GlycanIUPAC_T194","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G68566EA\""},{"id":"GlycanIUPAC_T195","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G68566EA\""},{"id":"GlycanIUPAC_T196","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G68566EA\""},{"id":"GlycanIUPAC_T197","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G20255ZD\""},{"id":"GlycanIUPAC_T198","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G20255ZD\""},{"id":"GlycanIUPAC_T199","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G20255ZD\""},{"id":"GlycanIUPAC_T200","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G20255ZD\""},{"id":"GlycanIUPAC_T201","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G68860MF\""},{"id":"GlycanIUPAC_T202","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G68860MF\""},{"id":"GlycanIUPAC_T203","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G68860MF\""},{"id":"GlycanIUPAC_T204","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G68860MF\""},{"id":"GlycanIUPAC_T205","span":{"begin":716,"end":719},"obj":"\"http://rdf.glycoinfo.org/glycan/G50413KD\""},{"id":"GlycanIUPAC_T206","span":{"begin":958,"end":961},"obj":"\"http://rdf.glycoinfo.org/glycan/G50413KD\""},{"id":"GlycanIUPAC_T207","span":{"begin":1049,"end":1052},"obj":"\"http://rdf.glycoinfo.org/glycan/G50413KD\""},{"id":"GlycanIUPAC_T208","span":{"begin":1367,"end":1370},"obj":"\"http://rdf.glycoinfo.org/glycan/G50413KD\""},{"id":"GlycanIUPAC_T209","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T210","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T211","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T212","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T213","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T214","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T215","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T216","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T217","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T218","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T219","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T220","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T221","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T222","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T223","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T224","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T225","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T226","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T227","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T228","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T229","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T230","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T231","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T232","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T233","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T234","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T235","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T236","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T237","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T238","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T239","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T240","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T241","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T242","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T243","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T244","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T245","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T246","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T247","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T248","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T249","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T250","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T251","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T252","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T253","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T254","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T255","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T256","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T257","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T258","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T259","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T260","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T261","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T262","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T263","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T264","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T265","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T266","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T267","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T268","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T269","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T270","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T271","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T272","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T273","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T274","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T275","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T276","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T277","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T278","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T279","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T280","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T281","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T282","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T283","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T284","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T285","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T286","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T287","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T288","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T289","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T290","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T291","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T292","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T293","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T294","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T295","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T296","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T297","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T298","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T299","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T300","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T301","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T302","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T303","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T304","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T305","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T306","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T307","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T308","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T309","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T310","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T311","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T312","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T313","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T314","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T315","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T316","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T317","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T318","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T319","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T320","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T321","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T322","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T323","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T324","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T325","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T326","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T327","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T328","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T329","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T330","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T331","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T332","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T333","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T334","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T335","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T336","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T337","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T338","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T339","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T340","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T341","span":{"begin":967,"end":973},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""},{"id":"GlycanIUPAC_T342","span":{"begin":1058,"end":1064},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""},{"id":"GlycanIUPAC_T343","span":{"begin":1375,"end":1381},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    Anatomy-MAT

    {"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":315,"end":321},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000484"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    Lectin-Jamboree

    {"project":"Lectin-Jamboree","denotations":[{"id":"T1","span":{"begin":397,"end":404},"obj":"lectin"},{"id":"T2","span":{"begin":1272,"end":1278},"obj":"lectin"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    Lectin-Jamboree-Sentence

    {"project":"Lectin-Jamboree-Sentence","blocks":[{"id":"T1","span":{"begin":0,"end":135},"obj":"Sentence"},{"id":"T2","span":{"begin":136,"end":418},"obj":"Sentence"},{"id":"T3","span":{"begin":419,"end":632},"obj":"Sentence"},{"id":"T4","span":{"begin":633,"end":768},"obj":"Sentence"},{"id":"T5","span":{"begin":769,"end":977},"obj":"Sentence"},{"id":"T6","span":{"begin":978,"end":1207},"obj":"Sentence"},{"id":"T7","span":{"begin":1208,"end":1374},"obj":"Sentence"},{"id":"T8","span":{"begin":1375,"end":1385},"obj":"Sentence"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}

    Anatomy-UBERON

    {"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":19,"end":27},"obj":"Body_part"},{"id":"T4","span":{"begin":166,"end":174},"obj":"Body_part"},{"id":"T7","span":{"begin":1258,"end":1271},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/GO_0016020"},{"id":"A2","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000094"},{"id":"A3","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/GO_0016020"},{"id":"A5","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000094"},{"id":"A6","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/GO_0005622"}],"text":"Vesicular-integral membrane protein, VIP36, recognizes high-mannose type glycans containing alpha1--\u003e2 mannosyl residues in MDCK cells.\nThe 36 kDa vesicular-integral membrane protein, VIP36, has been originally isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes containing apical marker proteins, and its luminal domain shows homology to leguminous plant lectins and ERGIC-53. As the first step to identify the functional role of VIP36, the carbohydrate binding specificity of VIP36 was investigated using a fusion protein of glutathione- S -transferase and luminal domain of VIP36 (Vip36). It was found that VIP36 recognizes high-mannose type glycans containing alpha1--\u003e2 Man residues and alpha-amino substituted asparagine. The binding of Vip36 to high-mannose type glycans was independent of Ca(2+)and theoptimal condition was pH 6.0 at 37 degrees C. The concentration at which half inhibition of the binding by Man(7-9).GlcNAc(2). N Ac. Asn occurred was 1.0 x 10(-9)M. The association constant between Man(7-9).GlcNAc(2)in porcine thyroglobulin and immobilized Vip36 was 2.1 x 10(8)M(-1)as determined by means of a biosensor based on surface plasmon resonance. These results indicate that VIP36 functions as an intracellular lectin recognizing glycoproteins which possess high-mannose type glycans, (Manalpha1--\u003e2)(2-4).Man(5). GlcNAc(2)."}